series-a
Stage
2
Investors
About
Syantra develops Onco-ID™, a cancer detection platform that identifies early shifts in normal body systems to detect cancer onset earlier by leveraging immune system signals rather than directly detecting cancer cells.
Explore Syantra's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.